Discussing Updates in the Management of Patients With Metastatic Melanoma
Source: Targeted Oncology, December 2022
Marc S. Ernstoff, MD, branch chief for the ImmunoOncology branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, at the National Cancer Institute, discusses metastatic melanoma and how patients may be managed.
Once melanoma spreads, the disease is known as metastatic melanoma. This type of melanoma occurs during stage 3 or stage 4.
According to Ernstoff, it’s important to have one’s melanoma molecularly defined as understanding the melanoma allows the development of specific small molecules to target mutations, including BRAF, and the downstream protein, MEK.